Search articles, concepts, and chapters
86 articles in GJC
Lam Byron L, Feuer William J, Porciatti Vittorio, Davis Janet L, Zheng D Diane, Vanner Elizabeth A et al.
Gene therapy for LHON showed asymptomatic eyes might be too advanced for neuroprotection, suggesting early intervention is key.
Gedde Steven J, Feuer William J, Lim Kin Sheng, Barton Keith, Goyal Saurabh, Ahmed Iqbal I et al.
The PTVT study found trabeculectomy had more early complications than tube shunts for glaucoma. However, serious complications, late complications, and cataract progression were similar between groups over five years.
Gedde Steven J, Feuer William J, Lim Kin Sheng, Barton Keith, Goyal Saurabh, Ahmed Iqbal I et al.
This 5-year study found trabeculectomy and tube shunts similarly controlled IOP in primary glaucoma, but trabeculectomy required fewer medications, guiding surgical choice.
Bowden Eileen C, Choudhury Anjalee, Gedde Steven J, Feuer William J, Christakis Panos G, Savatovsky Eleonore et al.
This study identified lower preoperative IOP, neovascular glaucoma, Ahmed implants, and younger age as key predictors of tube shunt failure, guiding surgical planning.
Khodeiry Mohamed M, Sheheitli Huda, Sayed Mohamed S, Persad Patrice J, Feuer William J, Lee Richard K
Slow coagulation TSCPC effectively lowered IOP and medication use in pseudophakic glaucoma patients, especially with higher baseline IOP, showing good safety as an initial treatment.
Vanner Elizabeth A, Sun Catherine Q, McSoley Matthew J, Persad Patrice J, Feuer William J, Lum Flora et al.
Vanner Elizabeth A, Sun Catherine Q, McSoley Matthew J, Persad Patrice J, Feuer William J, Lum Flora et al.
This study compared real-world (IRIS Registry) tube vs. trabeculectomy outcomes. It found real-world tube shunt failure rates were higher than in the RCT, suggesting real-world practice differences impact outcomes.
Vanner Elizabeth A, Sun Catherine Q, McSoley Matthew J, Persad Patrice J, Feuer William J, Lum Flora et al.
This study found real-world registry data for glaucoma surgeries (tube vs. trabeculectomy) had significant baseline differences and poorer follow-up compared to a controlled trial, limiting direct comparisons and generalizability.
Gedde Steven J, Feuer William J, Chen Philip P, Heuer Dale K, Singh Kuldev, Wright Martha M
Patient differences, especially preoperative IOP, explained varying surgical failure rates when comparing two glaucoma tube shunt studies, highlighting patient selection's impact on outcomes.
Swaminathan Swarup S, Jammal Alessandro A, Kornmann Helen L, Chen Philip P, Feuer William J, Medeiros Felipe A et al.
The TVT Study found no significant difference in visual field loss rates between tube shunts and trabeculectomy, but diabetes, higher IOP, and worse baseline VF predicted faster progression, guiding patient risk assessment.
Gedde Steven J, Feuer William J, Lim Kin Sheng, Barton Keith, Goyal Saurabh, Ahmed Iqbal I K et al.
Comparing tube shunts and trabeculectomy for uncontrolled glaucoma, both had similar 3-year failure rates. Trabeculectomy achieved lower IOP with fewer medications, but serious complications were similar for both procedures.
Grover Davinder S, Smith Oluwatosin, Fellman Ronald L, Godfrey David G, Gupta Aditi, Montes de Oca Ildamaris et al.
GATT surgery for open-angle glaucoma showed significant, safe IOP and medication reduction over 24 months, offering a viable long-term treatment option.
Gedde Steven J, Feuer William J, Shi Wei, Lim Kin Sheng, Barton Keith, Goyal Saurabh et al.
Trabeculectomy with MMC achieved better IOP control and success than tube shunts at one year, but tube shunts had fewer serious complications, guiding initial surgical choice for uncontrolled glaucoma.
Swaminathan Swarup S, Bhakta Amitabha S, Shi Wei, Feuer William J, Abreu Alexandre R, Chediak Alejandro D et al.
This study found no significant relationship between obstructive sleep apnea (OSAS) and glaucoma progression or visual field loss rate, suggesting OSAS severity may not directly impact glaucoma worsening.
Gedde Steven J, Chen Philip P, Heuer Dale K, Singh Kuldev, Wright Martha M, Feuer William J et al.
This study compares tube shunts and trabeculectomy with mitomycin C for uncontrolled glaucoma, aiming to determine which primary surgery is more effective, providing crucial data for clinical practice.
Emanuel Matthew E, Grover Davinder S, Fellman Ronald L, Godfrey David G, Smith Oluwatosin, Butler Michelle R et al.
MP-TSCPC effectively lowered IOP and medication use in refractory glaucoma, offering a viable alternative for patients with limited visual potential or high surgical risk, despite some short-term complications.
Vinod Kateki, Gedde Steven J, Feuer William J, Panarelli Joseph F, Chang Ta C, Chen Philip P et al.
A survey of glaucoma specialists found trabeculectomy with MMC remains the most popular primary surgery, but glaucoma drainage device use has significantly increased over two decades, impacting surgical choices.
Guy John, Feuer William J, Davis Janet L, Porciatti Vittorio, Gonzalez Phillip J, Koilkonda Rajeshwari D et al.
This study found low/medium-dose gene therapy for LHON was safe and improved vision in treated eyes, suggesting promise for further testing of higher doses.
Porciatti Vittorio, Feuer William J, Monsalve Pedro, Triolo Giacinto, Vazquez Luis, McSoley John et al.
Head-down posture-induced changes in eye pressure, blood pressure, and retinal electrical activity predict future optic nerve damage in glaucoma suspects, identifying high-risk individuals for earlier intervention.
Kotecha Aachal, Feuer William J, Barton Keith, Gedde Steven J
This study compared vision-specific quality of life after tube shunt versus trabeculectomy in glaucoma patients, finding both surgeries had similar patient-reported outcomes, even in advanced disease.
McCulley Timothy J, Lam Byron L, Feuer William J
Grover Davinder S, Godfrey David G, Smith Oluwatosin, Shi Wei, Feuer William J, Fellman Ronald L
GATT effectively lowered IOP and medication use in eyes with prior incisional glaucoma surgery, offering a safe, successful option for patients failing traditional procedures.
Vinod Kateki, Brandt James D, Gedde Steven J, Feuer William J, Shi Wei
Iverson Shawn M, Schultz Scott K, Shi Wei, Feuer William J, Greenfield David S
Filtration surgery achieving single-digit IOP targets significantly reduced visual field progression in progressive normal-tension glaucoma, highlighting aggressive IOP lowering's benefit for these patients.
Panarelli Joseph F, Banitt Michael R, Gedde Steven J, Shi Wei, Schiffman Joyce C, Feuer William J
This study found Baerveldt implantation and trabeculectomy with MMC had similar success and complication rates for primary glaucoma surgery, offering both as viable options.